Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ixcela
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ixcela

Ixcela

Series A

Ixcela: Enhancing health and athletic performance through gut microbiome balance.

HQ
Bedford, MA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Ixcela, founded with the mission to enhance health and athletic performance through gut microbiome balance, focuses on providing personalized health solutions. The company offers advanced functional gut microbiome testing and custom-tailored programs that include metabolite analysis and guidance from registered dietitian nutritionists. Ixcela aims to help individuals improve their overall well-being, athletic performance, and manage chronic health conditions by addressing gut microbiome dysbiosis.

Notable figures associated with Ixcela include experts in the fields of nutrition and health sciences. The company has garnered attention for its innovative approach to gut health, receiving investments from health-focused venture capital firms. Key achievements include the development of proprietary metabolite testing technology and the successful implementation of personalized health programs that have positively impacted numerous clients. Ixcela's work contributes significantly to the growing understanding of the gut microbiome's role in overall health.

Ixcela - Similar Companies

Injoy logo

Injoy

injoy.bio

Ombre logo

Ombre

ombrelab.com

Viome logo

Viome

viome.com

Biohm Health logo

Biohm Health

biohmhealth.com

FloraSeq logo

FloraSeq

Tend Health logo

Tend Health

tend-health.com

Ikaria logo

Ikaria

withikaria.com

Vitract logo

Vitract

vitract.com

Jona logo

Jona

jona.health

Nexilico logo

Nexilico

nexilico.com

Snapi Health logo

Snapi Health

snapihealth.com

Cypress Health logo

Cypress Health

cypresshealth.io

Elysium Health logo

Elysium Health

elysiumhealth.com

BiomeSense logo

BiomeSense

biomesense.com

Petri Bio logo

Petri Bio

petribio.com

Ixcela - Quick Facts

Who are Ixcela's competitors?

Companies similar to Ixcela include Injoy, Ombre, Viome and Biohm Health.

When was Ixcela founded?

Ixcela was founded in 2012.

Where is Ixcela's headquarters located?

Ixcela's headquarters is located in Bedford, MA, US.

When was Ixcela's last funding round?

Ixcela's most recent funding round was for $3.8M (USD) in October 2020.

How much has Ixcela raised to-date?

As of Oct 14, 2020, Ixcela has raised a total of $8M (USD).

How many employees does Ixcela have?

Ixcela has 36 employees as of Feb 5, 2024.

Ixcela - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Gut Microbiome Tests
Tags
  • eCommerce
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified